December 18, 2024

The final publication from #MusahLab for 2024 is out and open access! Our latest review article delves into the role of epigenetic markers and mechanisms in hypertensive nephropathy, a major contributor to chronic kidney disease, organ failure, and rising healthcare costs. We explore how epigenetic targets may influence disease progression and highlight exciting opportunities for novel therapeutic strategies.
Congratulations to our PhD students and coauthors, Yize Zhang, Hamidreza Arzaghi, Zhehan Ma, and Yasmin Roye, for their excellent teamwork and contributions to this work!
Full open access paper: Epigenetics of Hypertensive Nephropathy